Ohio man admits role in multi-million dollar scheme to defraud health care benefit programs | USAO-NJ


NEWARK, NJ – An Ohio man pleaded guilty today to his role in a large-scale, multi-layered marketing scheme to defraud private and federally funded health care benefit programs, announced US Attorney Philip R. Sellinger.

Kent Courtheyn, 38, of Kent, Ohio, owner and operator of two marketing companies involved in the sale and marketing of compound medicines – IntegriMed Solutions LLC (IntegriMed) and KA Compounding LLC (KA Compounding) – pleaded guilty by videoconference before U.S. District Judge Madeline Cox Arleo to a brief charging him with conspiracy to defraud the United States by committing health care fraud and violating anti-bribery law.

According to documents filed in this case and statements made in court:

TRICARE is a U.S. Department of Defense (DoD) Military Health System health care program that provides coverage to DoD beneficiaries worldwide, including active duty service members, members of the National Guard and of the Reserve, retirees, their families and survivors. Compound medications are specialty medications prepared by a pharmacist to meet the specific medical needs of a patient. Although compound drugs are not approved by the Food and Drug Administration (FDA), they are properly prescribed when a medical professional determines that an FDA-approved drug does not meet a patient’s health needs. particular, for example when a patient is allergic to a dye or other ingredient or when a patient cannot consume a medicine by traditional means.

From July 2014 to July 2016, Courtheyn, a former medical device sales representative, led a large-scale scheme to defraud federally funded health care benefit programs, such as TRICARE, as well as health care programs. privately funded health care delivery. Through IntegriMed and KA Compounding, Courtheyn recruited people to submit fraudulent claims for medically unnecessary compounded drugs, such as pain creams, scar creams, wound creams and vitamins. metabolic, regardless of medical necessity. In total, Courtheyn defrauded health care benefit programs, including TRICARE, of at least $5.8 million.

Courtheyn faces a legal maximum of five years in prison and a $250,000 fine, or double the gross gain or loss of the offense, whichever is greater. Judgment is scheduled for July 20, 2022.

U.S. Attorney Sellinger credited FBI Special Agents, under Special Agent in Charge George M. Crouch Jr. in Newark; and the U.S. Department of Defense, Office of Inspector General, Defense Criminal Investigative Service, Northeast Field Office, under the direction of Special Agent in Charge Patrick J. Hegarty, the investigation in course leading to today’s guilty plea.

The government is represented by Assistant U.S. Attorney Osmar J. Benvenuto, deputy chief of the Newark Criminal Division.


Comments are closed.